Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(12)70414-x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2012
Authors
Publisher
Elsevier BV